{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:17:30Z","timestamp":1770902250266,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijregi.2025.100741","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:54:07Z","timestamp":1757087647000},"page":"100741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HIV-1 genetic diversity and pretreatment drug resistance survey prior to dolutegravir introduction in Senegal"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4992-5126","authenticated-orcid":false,"given":"Mengue","family":"Fall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafissatou","family":"Leye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatou","family":"Niasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond","family":"Tchiakpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bambo","family":"Diakhaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mame Salane","family":"Thiam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abou Abdallah Malick","family":"Diouara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien Roch","family":"Niama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiatou","family":"Thiam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coumba","family":"Toure-Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halimatou","family":"Diop-Ndiaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2025.100741_bib0001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/QAD.0b013e328326ca77","article-title":"Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996\u20132006 in France","volume":"23","author":"Chaix","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ijregi.2025.100741_bib0002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(11)70255-9","article-title":"Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study","volume":"12","author":"Hamers","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100741_bib0003","first-page":"255","article-title":"R\u00e9sistance du VIH aux inhibiteurs non nucl\u00e9osidiques de la transcriptase inverse (INNTI)","volume":"10","author":"Delaugerre","year":"2006","journal-title":"Virologie"},{"key":"10.1016\/j.ijregi.2025.100741_bib0004","first-page":"381","article-title":"Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort","volume":"62","author":"De Beaudrap","year":"2013","journal-title":"JAIDS"},{"key":"10.1016\/j.ijregi.2025.100741_bib0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/cit627","article-title":"Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the WHO public health approach in Sub-Saharan Africa and Southeast Asia","volume":"58","author":"Aghokeng","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100741_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jmv.23778","article-title":"Dried blood spots for HIV-1 drug resistance genotyping in decentralized settings in Senegal","volume":"86","author":"Diouara","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijregi.2025.100741_bib0007","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018777","article-title":"High resistance to reverse transcriptase inhibitors among persons infected with HIV-1 subtype CRF02_AG in Ghana and on antiretroviral therapy","volume":"99","author":"Deletsu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijregi.2025.100741_bib0008","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.17.1.19315","article-title":"Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry","volume":"17","author":"Diouara","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijregi.2025.100741_bib0009","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/QAD.0000000000000906","article-title":"Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo","volume":"29","author":"Konou","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.ijregi.2025.100741_bib0010","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/cid\/civ656","article-title":"Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa","volume":"61","author":"Boender","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100741_bib0011","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/v15081683","article-title":"Laboratory based surveillance of HIV-1 acquired drug resistance in Cameroon: implications for use of tenofovir-lamivudine-dolutegravir as second- or third-line regimens","volume":"15","author":"Fokam","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ijregi.2025.100741_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/aid.2009.0295","article-title":"Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal","volume":"26","author":"Diop-Ndiaye","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ijregi.2025.100741_bib0013","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s13104-018-3804-9","article-title":"Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea","volume":"11","author":"Mbange","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijregi.2025.100741_bib0014","article-title":"Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2025.100741_bib0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-022-07453-9","article-title":"HIV-1 drug resistance genotyping success rates and correlates of dried-blood spots and plasma specimen genotyping failure in a resource-limited setting","volume":"22","author":"Omooja","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100741_bib0016","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(18)30710-2","article-title":"Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens","volume":"19","author":"Inzaule","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100741_bib0017","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1093\/cid\/ciaa1161","article-title":"Pretreatment and acquired antiretroviral drug resistance among persons living with HIV in four African countries","volume":"73","author":"Crowell","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100741_bib0018","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jmv.23860","article-title":"Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania","volume":"86","author":"Fall-Malick","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijregi.2025.100741_bib0019","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1139\/gen-2020-0112","article-title":"Determination of reverse transcriptase inhibitor resistance mutations in HIV-1 infected children in C\u00f4te d\u2019Ivoire","volume":"64","author":"Camara-Cisse","year":"2021","journal-title":"Genome"},{"key":"10.1016\/j.ijregi.2025.100741_bib0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13104-020-05151-w","article-title":"Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin","volume":"13","author":"Tchiakpe","year":"2020","journal-title":"BMC Res Notes"},{"issue":"Suppl 3","key":"10.1016\/j.ijregi.2025.100741_bib0021","first-page":"S31","article-title":"Faible taux de survenue de souches VIH-1 r\u00e9sistantes aux ARV chez des patients sous traitement antir\u00e9troviral au S\u00e9n\u00e9gal","volume":"17","author":"Tour\u00e9","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ijregi.2025.100741_bib0022","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meegid.2016.05.017","article-title":"Phylodynamics of the major HIV-1 CRF02_AG African lineages and its global dissemination","volume":"46","author":"Mir","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijregi.2025.100741_bib0023","series-title":"Enjeux de la prise en charge th\u00e9rapeutique du VIH au S\u00e9n\u00e9gal","author":"Ngom","year":"2018"},{"key":"10.1016\/j.ijregi.2025.100741_bib0024","first-page":"165","article-title":"Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries","volume":"29","author":"Vergne","year":"2002","journal-title":"JAIDS"},{"key":"10.1016\/j.ijregi.2025.100741_bib0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4102\/ajlm.v4i1.168","article-title":"Quantification de la charge virale et tests de r\u00e9sistance du VIH-1 aux ARV \u00e0 partir d\u2019\u00e9chantillons DBS chez des patients Guin\u00e9ens sous traitement antir\u00e9troviral","volume":"4","author":"Bangoura","year":"2015","journal-title":"Afr J Lab Med"},{"key":"10.1016\/j.ijregi.2025.100741_bib0026","article-title":"High HIV-1 virological failure and drug resistance among adult patients receiving first-line ART for at least 12 months at a decentralized urban HIV clinic setting in Senegal before the Test-and-Treat","volume":"14","author":"Ekollo","year":"2021","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.ijregi.2025.100741_bib0027","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0300","article-title":"High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to WHO guidelines","volume":"29","author":"Kebe","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ijregi.2025.100741_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12887-019-1420-z","article-title":"High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal","volume":"19","author":"Ciss\u00e9","year":"2019","journal-title":"BMC Pediatr"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625001766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625001766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:22:51Z","timestamp":1770898971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707625001766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S2772707625001766"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100741","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 genetic diversity and pretreatment drug resistance survey prior to dolutegravir introduction in Senegal","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100741"}}